The global electrophoresis reagents market is experiencing steady growth as advancements in molecular biology, genomics, and clinical diagnostics continue to increase the demand for high-quality laboratory reagents. According to Fortune Business Insights, the global electrophoresis reagents market size was valued at USD 1.36 billion in 2025 and is projected to grow from USD 1.44 billion in 2026 to USD 2.34 billion by 2034, exhibiting a CAGR of 6.21% during the forecast period.
Electrophoresis reagents are essential for separating DNA, RNA, and proteins in research and diagnostic laboratories. Their growing use in genetic testing, drug discovery, cancer research, forensic science, and biotechnology is expected to support long-term market expansion.
Electrophoresis reagents are specialized chemicals and solutions used during electrophoresis, a laboratory technique that separates biomolecules based on their size and electrical charge. Common reagents include agarose, polyacrylamide, electrophoresis buffers, loading dyes, staining solutions, molecular weight markers, and gel preparation chemicals.
These reagents play a critical role in life science research, pharmaceutical development, academic laboratories, and clinical diagnostics by ensuring accurate and reliable separation of biological samples.
The increasing prevalence of genetic disorders, infectious diseases, and cancer is driving demand for molecular diagnostic testing worldwide. Electrophoresis remains an important technique for analyzing DNA and proteins, creating consistent demand for high-quality reagents.
As precision medicine becomes more widely adopted, laboratories require reliable electrophoresis reagents to support accurate disease diagnosis and personalized treatment strategies.
Governments, pharmaceutical companies, and biotechnology firms are investing heavily in genomics, proteomics, and molecular biology research. Electrophoresis is widely used throughout these research activities to analyze nucleic acids and proteins.
The expansion of biotechnology research centers and academic institutions continues to increase the consumption of electrophoresis reagents across global laboratories.
Pharmaceutical companies rely on electrophoresis techniques during drug discovery, quality control, and biopharmaceutical manufacturing. Researchers use electrophoresis reagents to evaluate protein purity, characterize biomolecules, and monitor manufacturing processes.
As biologics, biosimilars, and gene therapies continue to gain importance, demand for advanced laboratory reagents is expected to grow steadily.
Clinical laboratories are adopting advanced diagnostic technologies to improve testing accuracy and efficiency. Electrophoresis is commonly used for protein analysis, hemoglobin testing, serum protein evaluation, and genetic analysis.
The growing number of diagnostic laboratories worldwide is expected to further strengthen market demand throughout the forecast period.
Automation is becoming a major trend in electrophoresis workflows. Modern laboratories are integrating automated electrophoresis systems that reduce manual intervention while improving testing speed and reproducibility.